Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11

17 octobre 2017

16:37
NEW YORK and BERLIN, Oct. 17, 2017 /PRNewswire/ -- MeiraGTx, a New York and London based gene therapy company, today announced the presentation of preclinical data from studies in animal models of Leber's congenital amaurosis (LCA2), achromatopsia,...

16:05
RICHMOND, Calif., Oct. 17, 2017 /PRNewswire/ --Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today presentations by Company scientists at the 2017 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT). The meeting is being...

15:54
ROSEMONT, Ill., Oct. 17, 2017 /PRNewswire-USNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) today announced plans to create a national family of clinical data registries for a broad range of orthopaedic conditions and procedures. As...

14:55
CLIA Sanger Sequencing also launched along with the announcement of a new PacBio® SMRT® Grant Program SOUTH PLAINFIELD, New Jersey and ORLANDO, Florida, Oct. 17, 2017 /PRNewswire/ -- ASHG17, Booth #323 -- Leading global genomics service provider,...

13:00
SAN FRANCISCO, Oct. 17, 2017 /PRNewswire/ -- goBalto, Inc., the leading provider of cloud-based clinical study startup (SSU) solutions, announced today its latest release of goBalto Activate. The third major release of 2017 offers new features that...

12:51
YOKNEAM, Israel, Oct. 17, 2017 /PRNewswire/ -- Lumenis Ltd., the world's largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced today that it will share new clinical data on its CO2 laser-based...

12:45
TORONTO, Oct. 17, 2017 /PRNewswire/ -- Alpha Cancer Technologies Inc. (ACT) a biopharmaceutical company focused on therapies for patients with autoimmune diseases and cancer, today announced the results of a study of ACT-101 (recombinant human alpha...

12:17
NESS ZIONA, Israel, October 17, 2017 /PRNewswire/ -- NRGene, the worldwide leader in genomic assembly and analysis, has demonstrated its ability to discover, analyze, and track abnormalities within the human genome, across multiple subjects. As...

10:17
NEW YORK, Oct. 17, 2017 /PRNewswire-USNewswire/ -- Most ? and possibly all ? ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.  This is the finding of a multicenter study of...

09:30
MIAMI, Oct. 17, 2017 /PRNewswire/ -- Longeveron LLC, a leading life sciences company developing innovative therapies for age-related diseases, announced that the company is progressing with the development of its stem cell treatment to...

09:00
VEJLE, Denmark, Oct. 17, 2017 /PRNewswire/ -- ARCEDI Biotech ApS, a company developing technologies for rare fetal cell detection for use in prenatal diagnostic applications, today announced the publication of data suggesting the Company's cell-based...

09:00
ST. PAUL, Minn., Oct. 17, 2017 /PRNewswire/ -- Two new studies by pharmacy benefit manager Prime Therapeutics LLC (Prime) show commercially insured members with rheumatoid arthritis (RA) had 3.5 times higher total cost of care than members without...

08:40
JERUSALEM, Oct. 17, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the publication of a new paper...

08:30
HARRISBURG, Pa., Oct. 17, 2017 /PRNewswire/ -- Why is one more National Institute of Health (NIH) study involving the microbiome so important? Because, says Prebiotin CEO Ron Walborn Jr., "This one featured a natural prebiotic fiber supplement,...

08:30
CLEVELAND, Oct. 17, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the world's first and only clinical MRI-guided radiation therapy system, announced today outcomes data presented during the recent 2017 Annual Meeting of the American...

08:30
AUSTIN, Texas and BUFFALO, N.Y., Oct. 17, 2017 /PRNewswire/ -- ePatientFinder®, a research delivery network and leader in electronic health record (EHR) patient identification, and Circuit Clinical, a practice-based clinical research site network,...

08:15
PALO ALTO, Calif., Oct. 17, 2017 /PRNewswire/ -- Varian (NYSE: VAR) today announced an 80-year-old male with head & neck cancer became the first patient in Europe to be treated on the Halcyontm system at University Hospitals Leuven (UZ Leuven) in...

08:09
MEMPHIS, Tenn., Oct. 17, 2017 /PRNewswire/ -- Transnetyx, an automated genotyping company that serves biomedical researchers worldwide, today announced the premier of the documentary, "Brick in the Wall," as part of its storytelling collection, the...

08:07
WOODBRIDGE, Conn. and WARSAW, Poland, Oct. 17, 2017 /PRNewswire/ -- PlumCare, a DNA advisory service for families, today announced a partnership with PBKM FamiCord, the European leader in cord blood stem cell banking.  The new collaboration will...

08:00
SAN DIEGO, Oct. 17, 2017 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that updated data from the company's Phase 1 study of Toca 511 & Toca FC in recurrent high grade glioma...

08:00
CARLSBAD, Calif. and ORLANDO, Fla., Oct. 17, 2017 /PRNewswire/ -- Inherited diseases are genetically passed down from parent to child through abnormalities in the genome or DNA sequence. These variants can be caused by a single-gene mutation or a...

07:30
MARIETTA, Ga., Oct. 17, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected...

07:30
SAN FRANCISCO, Oct. 17, 2017 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, is presenting data showing genetic sequencing and copy number variant (CNV) detection performed together using...

07:00
SHELTON, Conn., Oct. 17, 2017 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company") will present the results of its anti-herpes nanoviricide treatment for Viral Acute Retinal Necrosis (vARN) at the 2017 Annual meeting of the...

07:00
SAN DIEGO, Oct. 17, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today...

07:00
CAMBRIDGE, Mass., Oct. 17, 2017 /PRNewswire/ -- Precision neuroscience company Cadent Therapeutics has earned a milestone payment from Novartis for the initiation of a Phase 1 clinical study of a subtype selective NMDA receptor negative allosteric...

05:56
WAVRE, Belgium, October 17, 2017 /PRNewswire/ -- iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the completion of enrolment in their first-in-human (FIH)...

04:00
COPENHAGEN, Denmark, October 17, 2017 /PRNewswire/ -- MagVenture A/S, a global medical device company, has established a subsidiary in the UK. MagVenture specializes in magnetic stimulation, a technology used within the fields of neuro-diagnostics...


16 octobre 2017

18:47
AMSTERDAM, October 16, 2017 /PRNewswire/ -- Norgine B.V. a présenté aujourd'hui de nouvelles données qui démontrent l'efficacité d'un nettoyage de plus grande qualité des intestins (du moins sur l'un des segments du côlon) de PLENVU® (NER1006) par...

13:23
AMSTERDAM, October 16, 2017 /PRNewswire/ -- Norgine B.V. a annoncé aujourd'hui qu'elle présente six affiches lors du Congrès mondial de gastroentérologie au Collège américain de gastroentérologie (ACG), à Orlando, Floride, États-Unis, du 13 au 16...

13:00
- Chk1 inhibitor SRA737 demonstrates chemical synthetic lethality with replication stress-inducing agents, including potentiation by novel low-dose gemcitabine combination, in preclinical models of cancer - VANCOUVER, Oct. 16, 2017 /CNW/ - Sierra...

10:30
AMSTERDAM, October 16, 2017 /PRNewswire/ -- Norgine B.V. today presented new data demonstrating the superior high-quality bowel cleansing efficacy (in at least one segment of the colon) of PLENVU® (NER1006) compared to two widely used alternative...

09:00
BOSTON and STOCKHOLM, Oct. 16, 2017 /PRNewswire/ -- Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53, announced today that the first...

08:35
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Oct. 16, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") today announced that the soft exosuit technology currently in development has entered the next phase of testing and verification...

08:35
SARASOTA, Fla., Oct. 16, 2017 /PRNewswire/ -- Many people currently use herbal treatments to improve their health. However, some are still reluctant to use those treatments.  To discover why, a study asked 601 individuals about their perceptions of...

08:30
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Oct. 16, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") announced today completion of all internal processes to initiate clinical studies and the initial production of its "soft suit"...

08:17
AMSTERDAM, October 16, 2017 /PRNewswire/ -- Norgine B.V. today announced it is presenting six posters at the World Congress of Gastroenterology at the American College of Gastroenterology (ACG) in Orlando, Florida, USA, 13-16 October, 2017. Key data...

08:01
DUBLIN, Oct. 16, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that new data from its gastroenterology portfolio will be featured at the World Congress of Gastroenterology (WCOG), American College of Gastroenterology (ACG), from...

08:01
FREMONT, Calif., Oct. 16, 2017 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX) today reported that data from preclinical studies have shown that tenapanor works to reduce abdominal pain caused by irritable bowel syndrome with constipation (IBS-C)...

08:00
SAN DIEGO, Oct. 16, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced initiation of a clinical trial evaluating its investigational new drug PEGPH20 with atezolizumab (TECENTRIQ®), an anti-PDL1 cancer immunotherapy from...

08:00
TARRYTOWN, N.Y. and PARIS, Oct. 16, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced positive results from a Phase 2 investigational study of dupilumab in adults with active moderate-to-severe...

08:00
SAN DIEGO, October 16, 2017 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) believes it has taken full advantage of its recent prior discovery in developing small molecule drugs that activate NR2F6.  The Company recently...

08:00
BASEL, Switzerland, Oct. 16, 2017 /PRNewswire/ -- Enzyvant, a biopharmaceutical company focused on developing innovative treatments for patients with rare diseases, today announced the initiation of the Farber Disease Natural History Study. The...

08:00
OSAKA, Japan, Oct. 16, 2017 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (TSE: 4502), ("Takeda") today announced the presentation of data suggesting early symptomatic improvement in specific symptoms with Entyvio® (vedolizumab) in patients...

08:00
ROSEVILLE, Minn., Oct. 16, 2017 /PRNewswire/ -- Rebiotix Inc., a clinical-stage microbiome company focused on harnessing the power of the human microbiome to treat challenging diseases, today announced new clinical findings from the RBX2660 Phase 2...

07:45
PRINCETON, N.J., Oct. 16, 2017 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX), a women's healthcare company, today announced the presentation of additional results from the Phase 3 SECURE trial of its investigational low-dose combination...

06:45
INDIANAPOLIS, Oct. 16, 2017 /PRNewswire/ -- New subgroup analysis from Eli Lilly and Company's (NYSE: LLY) Phase 3 REVEL trial of CYRAMZA® (ramucirumab) in advanced non-small cell lung cancer (NSCLC) was presented today at the 18th World Conference...

05:45
LONDON and BUDAPEST, Hungary, October 16, 2017 /PRNewswire/ -- ChemPass, an artificial intelligence technology company and LifeArc, a medical research charity, announced today that they have successfully completed the first phase of their evaluation...

05:00
LONDON, October 16, 2017 /PRNewswire/ -- Dante Labs adds Non Invasive Prenatal Test (NIPT) to its collection of advanced genetic tests.  Today international biotech company Dante Labs introduced its Non-Invasive Prenatal Test (NIPT) based on Next...

00:40
HACKENSACK, N.J. and PETACH TIKVA, Israel, Oct. 16, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) today announced that the first patients have been enrolled in the Phase 3 clinical trial of NurOwn® for the treatment of...

1 2 3 4 5 6 7 8 9 10 11